How many drugs treat Rheumatic Fever Prevention?

Drug Landscape tracks 6 marketed treatments for Rheumatic Fever Prevention (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/rheumatic-fever-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Rheumatic Fever Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rheumatic Fever Prevention (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Rheumatic Fever Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Benzamycin	Erythromycin Lactobionate	Pfizer	Macrolide	Potassium voltage-gated channel subfamily H member 2	1964-01-01
E-Mycin	erythromycin	Generic (originally Abbott/Lilly)	Macrolide [EPC]	Aldehyde oxidase, Bile salt export pump, Cytochrome P450 1B1	1952-01-01
Penicillin G Potassium In Plastic Container	Benzylpenicillin	Pfizer	Penicillin-class Antibacterial		1947-01-01
Sulfadiazine	SULFADIAZINE	Eli Lilly	Sulfonamide Antibacterial [EPC]	5-hydroxytryptamine receptor 2A	1941-01-01
penicillin	penicillin	Karlstad University		Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM
Phenoxymethylpenicillin	Phenoxymethylpenicillin	Katarina Hedin		Bacterial penicillin-binding protein, Penicillin-binding protein 1A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 2 drugs in Rheumatic Fever Prevention
Eli Lilly · 1 drug in Rheumatic Fever Prevention
Generic (originally Abbott/Lilly) · 1 drug in Rheumatic Fever Prevention
Karlstad University · 1 drug in Rheumatic Fever Prevention
Katarina Hedin · 1 drug in Rheumatic Fever Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Rheumatic Fever Prevention:

Cite this brief

Drug Landscape (2026). Rheumatic Fever Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/rheumatic-fever-prevention. Accessed 2026-06-10.

Rheumatic Fever Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing